Category: Insomnia

Insomnia

Nox’s Acquisition of Somryst a ‘Major Milestone’

Nox Health recently agreed to pay $3.9 million to acquire the prescription digital therapeutic for chronic insomnia from Pear Therapeutics in its bankruptcy auction.

Insomnia

5 Relaxation Techniques for Sleep to Help People with Insomnia

Teach patients these relaxation exercises as part of their insomnia therapy.

Insomnia

Pear Considers Acquisition, Sale, Merger, or Other Strategic Alternatives

Pear Therapeutics is exploring strategic alternatives—including acquisition, sale, or merger—to maximize shareholder value.

Sleep Onset Insomnia

Vanda Preps sNDA for HETLIOZ in Insomnia

Vanda’s trial results of HETLIOZ (tasimelteon) for insomnia suggest that circadian misalignment may be the etiology behind chronic primary insomnia for many patients.

Sleep Maintenance Insomnia

United States Becomes First Country Where Insomnia Drug DAYVIGO Is Available

In clinical studies, DAYVIGO helped some people with insomnia fall asleep faster and stay asleep longer compared to placebo.

Early Awakening Insomnia

Insomnia in the Elderly Is Often Eclipsed by Other Disorders But Recognizing It Can Help Resolve Comorbidities

Geriatric populations are simultaneously more likely to have insomnia and less likely to tell their medical team about it.

Complex Insomnia

COMISA Impacts a Third of People with Insomnia or OSA. A Sleep Researcher Explains Why That Matters

The prevalence, possible etiological mechanisms, and suggested treatment order of comorbid insomnia and obstructive sleep apnea, as explained by a researcher on the team that coined the term ‘COMISA.’